MCM2 and lung carcinoma: Analysis of the p-MCM2/MCM2 ratio between early and advanced tumor stages of CRC and lung cancer groups resulted in a 1.27-fold increase (P < 0.01), and 1.44-fold elevation (P < 0.001) of p-MCM2/MCM2 ratio, respectively.